Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access               Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain DXCM message board posts where the ticker symbol DXCM has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest DXCM SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000236 Size: 4 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000235 Size: 12 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000234 Size: 9 KB
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001093557-18-000230 (34 Act)  Size: 5 MB
2018-11-06 000-51222
8-K  Documents Current report, item 2.02
Acc-no: 0001093557-18-000229 (34 Act)  Size: 282 KB
2018-11-06 000-51222
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000223 Size: 7 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000222 Size: 7 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000219 Size: 7 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000217 Size: 4 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000215 Size: 10 KB
More DXCM SEC Filings

Related news from
Tue, 13 Nov 2018
11:09:11 +0000
DexCom (DXCM) Beats Q3 Earnings Estimates, Raises '18 View
Solid contribution from the Sensor, Transmitter and Receiver segments drives DexCom's (DXCM) Q3 results.
Mon, 12 Nov 2018
12:00:00 +0000
Today's Research Reports on Trending Tickers: DexCom and BioTelemetry
NEW YORK, NY / ACCESSWIRE / November 12, 2018 / U.S. markets plunged Friday, with the Dow dropping over 200 points, as falling oil prices raised global economic concerns. The Dow Jones Industrial Average dropped 0.77 percent to close at 25,989.30, while the S&P 500 Index shed 0.92 percent to close at 2,781.01. The Nasdaq Composite Index decreased 1.65 percent higher to close at 7,406.90.
Fri, 09 Nov 2018
14:01:00 +0000
3 Growth Stocks Healthcare Investors Should Buy Now
Picking up shares in this research company, health insurer, and medical-device company could pay off for investors.
Thu, 08 Nov 2018
21:14:14 +0000
IBD Stock Of The Day Flirts With Breakout And Nears Annual Profitability
Dexcom stock is the IBD Stock Of The Day as it flirts with a breakout and looks to turn profitable. It makes glucose monitoring systems for diabetic patients.
Thu, 08 Nov 2018
13:51:01 +0000
DexCom (DXCM) Catches Eye: Stock Jumps 8.8%
DexCom (DXCM) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Wed, 07 Nov 2018
22:30:00 +0000
Dexcom to Host Investor Day on December 4, 2018
DexCom, Inc. today announced that it will host an Investor Day on December 4, 2018 at the Laguna Cliffs Marriott in Dana Point, California. The event will include updates on the company’s innovation pipeline, business strategy, and long-term financial outlook.
Wed, 07 Nov 2018
10:30:10 +0000
Edited Transcript of DXCM earnings conference call or presentation 6-Nov-18 9:30pm GMT
Q3 2018 DexCom Inc Earnings Call
Tue, 06 Nov 2018
22:15:10 +0000
DexCom (DXCM) Tops Q3 Earnings and Revenue Estimates
DexCom (DXCM) delivered earnings and revenue surprises of 241.67% and 10.17%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Tue, 06 Nov 2018
21:10:48 +0000
DexCom: 3Q Earnings Snapshot
On a per-share basis, the San Diego-based company said it had net income of 52 cents. Earnings, adjusted for non-recurring gains, came to 17 cents per share. The results surpassed Wall Street expectations. ...
Tue, 06 Nov 2018
21:01:00 +0000
DexCom Reports Third Quarter 2018 Financial Results
DexCom, Inc. today reported its unaudited financial results as of and for the quarter ended September 30, 2018.
Fri, 02 Nov 2018
18:41:18 +0000
7 Straight-A Stocks to Build a Portfolio Around
What’s more, each stock here has received A ratings across three categories (quantitative, sales growth and earnings growth) by Portfolio Grader. For example, after getting sustained criticism for its low-wage warehouse jobs, AMZN announced that it was raising minimum wages to $15 an hour. Netflix Inc (NASDAQ:NFLX) is another one of those disruptive companies spawned from simple beginnings that is now developing into a global force that is challenging legacy entertainment companies at every turn.
Tue, 23 Oct 2018
13:02:11 +0000
A Look into Johnson & Johnson’s Diabetes Care Business
Johnson & Johnson’s (JNJ) Diabetes Care segment generated revenues of $319.0 million in the third quarter, reflecting an ~22.2% YoY (year-over-year) decline and an 11.0% decline sequentially. Johnson & Johnson’s Diabetes Care segment reported an ~20.0% YoY operational decline in the third quarter.
Mon, 22 Oct 2018
11:45:00 +0000
Detailed Research: Economic Perspectives on DexCom, MiX Telematics, Resolute Forest Products, Equinix, Johnson & Johnson, and Vedanta — What Drives Growth in Today's Competitive Landscape
NEW YORK, Oct. 22, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Fri, 19 Oct 2018
11:32:16 +0000
Most Analysts Are Bullish on Tandem Stock
Seven of the total ten analysts covering Tandem Diabetes Care (TNDM) in October 2018 have given Tandem a “buy” or higher rating, and three analysts have given Tandem a “hold” rating. The mean rating for Tandem is 2.1 with a target price of $52.5, which implies an upside potential of 36.7% over Tandem’s trading price of $38.40 on October 17.
Thu, 18 Oct 2018
14:52:02 +0000
DexCom Launches CLARITY Mobile App, Strengthens CGM Profile
DexCom (DXCM) benefits from the diabetes care space as it adopts cloud-based services for Continuous Glucose Monitoring.
Thu, 18 Oct 2018
14:33:09 +0000
What Can We Expect from Tandem’s Bottom Line in Third Quarter?
Tandem Diabetes Care (TNDM) is expected to incur a net loss of $18.22 million in the third quarter of 2018. Its net loss was $16.03 million in the year-ago period, which translates into a net loss per share of $0.33 for the third quarter of fiscal 2018 as compared with a net loss per share of $3.09 for the third quarter of fiscal 2017. On October 12, Tandem announced that its t:slim X2 insulin pump received approval in Canada and is the only continuous glucose monitoring (or CGM) integrated insulin pump approved in the country.
Thu, 18 Oct 2018
12:00:00 +0000
Dexcom G6® Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries with Diabetes in Early 2019
DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today the new Dexcom G6® CGM System will be covered for Medicare beneficiaries, having met the category requirements for therapeutic CGM systems by the U.S. Centers for Medicare & Medicaid Services (CMS). Coverage for therapeutic CGM includes certain beneficiaries who have either Type 1 or Type 2 diabetes and intensively manage their insulin.
Fri, 12 Oct 2018
11:30:50 +0000
Could JNJ’s Medical Device Business Report Strong Growth in Q3?
Johnson & Johnson’s (JNJ) Medical Device business has posted steadily improving performance in recent quarters. Since then, Johnson & Johnson has efficiently implemented a restructuring plan for its Medical Device business, which resulted in significant growth in the segment’s performance. In the second quarter, Johnson & Johnson’s Medical Device business reported sales of ~$7.0 billion, which contributed 33.5% to the company’s total sales of $20.8 billion.
Thu, 11 Oct 2018
08:00:00 +0000
Dexcom Announces Release of Clarity Mobile App
EDINBURGH , October 11, 2018 /PRNewswire/ -- Mobile app allows patients to quickly access glucose data on their phone for diabetes management   Dexcom , Inc. (NASDAQ:DXCM), a leader in continuous glucose ...
Tue, 09 Oct 2018
13:24:01 +0000
The Zacks Analyst Blog Highlights: Masimo, Medtronic, Garmin and DexCom
The Zacks Analyst Blog Highlights: Masimo, Medtronic, Garmin and DexCom

"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "The most important thing I have learned at VF in the last 3 years reading all you smart peoples posts is money management. This is usually not taught by our parents." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards